[VRTX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
13-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 914.00%
YoY- -62.38%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 1,538,271 1,524,485 1,515,107 1,413,265 949,828 941,293 858,435 47.37%
PBT 745,871 824,770 657,534 676,950 70,666 327,138 320,165 75.46%
Tax 78,437 -12,500 54,781 93,716 13,148 59,711 51,534 32.21%
NP 667,434 837,270 602,753 583,234 57,518 267,427 268,631 83.13%
Tax Rate -10.52% 1.52% -8.33% -13.84% -18.61% -18.25% -16.10% -
Total Cost 870,837 687,215 912,354 830,031 892,310 673,866 589,804 29.57%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 43.39 54.92 39.78 41.27 6.06 28.41 31.29 24.27%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS 2.56 3.22 2.32 2.26 0.22 1.04 1.05 80.85%
EPS Diluted 2.53 3.18 2.29 2.23 0.22 1.03 1.03 81.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.